Gilbert Halley E insider trades
Gilbert Halley E has filed 20 Form 4s with the SEC that we hold, for Arcutis Biotherapeutics, Inc. (ARQT) (Director), Vaxcyte, Inc. (PCVX) (Director), CytomX Therapeutics, Inc. (CTMX) (Director) and Neogenomics INC (NEO) (Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 2 sales worth $1.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($455.5K). The largest single trade was a sale of 18,200 shares of Vaxcyte, Inc. worth $1.3M, dated 2024-06-03. The first filing on our record is dated 2021-08-19 and the latest 2026-06-22.
Arcutis Biotherapeutics, Inc. (ARQT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-20 | S, sale reported on Form 4 | 16,532 | $455.5K | 2025-11-21 |
Vaxcyte, Inc. (PCVX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-03 | S, sale reported on Form 4 | 18,200 | $1.3M | 2024-06-05 |
CytomX Therapeutics, Inc. (CTMX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Neogenomics INC (NEO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1601360) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms